Abstract
This study documents the effect of intravenous nitroglycerin (NTG) on tracheal smooth muscle in 12 patients undergoing coronary artery surgery. The pressure within a water-filled tracheal cuff was monitored continuously, as well as systemic and pulmonary arterial pressures. A significant decrease in cuff pressure after intravenous NTG (4.0 +/- 0.3 micrograms/kg) was detected before cardiopulmonary bypass (CPB). During CPB, with exclusion of the pulmonary arterial circulation, the tracheal cuff response to NTG administered into the oxygenator persisted and was not significantly different from that noted before CPB. Thus, the large airway (tracheal) response to NTG was independent of the pulmonary circulation and probably is mediated by the bronchial circulation. The response during CPB indicated that the tracheal smooth muscle retains tone and can respond to NTG even when the lungs are collapsed with no pulmonary arterial perfusion. These data were obtained from patients with no clinical evidence of reversible airway obstruction and indicate only that NTG relaxed human tracheal smooth muscle in vivo. These data do not demonstrate the efficacy of intravenous NTG in patients with asthma.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.